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·.Proposal  for  a 
COUNCIL  DIRECTIVE 
ON  THE  PROTECTION  OF  WORKERS  FROM  THE  RISKS  RELATED 
TO  EXPOSURE  TO  BIOLOGICAL  AGENTS  AT  WORK  -
(present•d  by  the  Commission) PROPOSAl  FOR  A COUHCIL  DIRECTIVE 
OH  THE  PROTECTIOH  OF  WORKERS  FORM  THE  RISKS  RELATED 
TO  EXPOSURE  TO  BIOLOGICAL  AGEHTS  AT  WORK 
EXPLANATORY  MEMORANDUM 
The  Co••unication of the Commission  of the  European  Co••unities on its 
program•e  concerning  safety,  hygiene  and  health at work  (1)  stated 
that  it  intended to.  make  a  proposal  for  a  Directive  on  biological 
agents  which  affect health,  such  as  pathogenic  •icroorganisas,  and 
genetic engineering techniques which  may  present  a  risk to health. 
A  strategy for controlling dangerous  agents  was  adopted  under Council 
Di~ective 80/1107/EEC  covering all  chemical,  physical  ~nd  biological 
agents  at the workplace.  Several  Council  Directives have  been  adopted 
on  chemical  agents  and  one  on  a  physical  agent  (noise>.  The  Co••ission 
has  not yet  proposed specific measures for biological  agents. 
It has,  however,  been  proved that many  biological  agents are  har•ful  to 
health,  and  hence that exposure to these  agents  increases the risk of 
disease.  Workers  can  beco•e  exposed to these agents in a  wide variety 
of  activities,  such  as  : 
- research  and  develop•ent laboratories, 
.,..  hospital  isolation units,. 
-clinical,  veterinary  and  diagnostic laboratories, 
- certain branches of  industry. 
<1>  Com  <520)  final It is particularly important that workers  in the  above-mentioned  areas 
of activity are  exposed to biological  agents  as little as possible,  if 
at  all,  in  order  to  prevent  them  from  developing  infections  or 
diseases. 
2.  ~Y,m9r~_Qf_rggyl9!i2na_Qn_g~e2aYrg_t2_bi2l2Di~9l_99gnta_9t_~2rk_in_tbg 
~iri2Ya_~gmbgr_~titga 
"ost  "e•ber States recognize the need  to protect workers  against  the 
risks related to exposure to biological  agents.  This •atter has  beco•e 
•ore i•portant with the  developMent  of  biotechnologies in which  biolo-
gical  agents that are dangerous for  people  can  be  used or produced. 
However,  this  question is dealt with  in  a  different way  in  the  na-
tional  legislation  of each "e•ber State.  In  so•e  cases,  national 
legislation  does  not  provide for  any  specific •easures.  The  •easures 
which  do  exist are mostly of a  general  nature  and  provide some  legal 
protection  against  the effects of  biological  agents.  Other  He•ber 
States already  apply quite detailed legislation,  but this often proves 
to  be  inadequate in some  areas,  particularly as  regards  biotechno-
logies. 
The  proposal  for  a  Directive referred to  here  aims  to protect workers 
against the risks to their health  and  safety arising from  exposure  to 
biological  agents  and  thus to  promote  the  progressive  harmonization of 
existing requirements  in the Member  States in this field. 
The  main  regulations  currently  in force  in the Me•ber States on  expo-
sure to biological  agents at work  are  described  below. 
BELGIUM 
A  safety survey must  be  carried out  and  safety instructions drawn  up 
before  a  new  process or activity is used at work  which  is likely  to 
pose  a  threat to the  health of workers  due  to the  presence of biologi-
cal  agents. 
2 EMployers  are  obliged  to take measures  to eliminate or  reduce  the 
danger  to workers if there is an  obvious risk of exposure to  biologi-
cal  agents. 
Medical  examinations are carried out  and  workers  are  given  infor•ation 
on  protective measures. 
Lastly,  there  are  specific provisions for  pregnant  wo•en,  and  for 
workers  under the  age  of  18,  as well  as for vaccinating workers  hand-
ling skin and  hair of  animal  origin against smallpox  and  tetanus. 
FEDERAL  REPUBLIC  OF  GERMANY 
List  of  the  relevant legal  provisions  and  directives in force  in  the 
Federal  Republic of Germany  concerning  biological  agents  : 
Law  on  the  prevention  and  control  of coa•unicable hu•an  diseases  <Bundes-
Seuchengesetz>  in  its  published version of  18  DeceMber  1979  <Bundes-
gesetzblatt I  p.  2262,  1980  p.  151>,  most  recently amended  by  the Law  of 
27  June  1985  CBGBl  I  p.  1254)  chap.  3,  8,  9,  19-29. 
Regulations on  pathogens of 21  Nove•ber  1917  <published in  Reic~sgesetz­
blatt .p.  1069,  BGBl  III  p.  2126-1-1)  chap.  1,  2. 
law  reforming the legislation on  pharmaceuticals of 24  August  1976  CBGBl 
I  p.  2445),  amended  by  the Law  of 24  February 1983  CBGBl  I  p.  169)  chap. 
4,  13-20,  32,  35. 
Law  on  livestock epideMics,  in its published version of 28  March  1980 
CBGBl  I  p.  386)  chap.  10. 
Order  concerning  the i•portation of live ani•al  pathogens  and  vaccines 
containing them  CTierseuchenerreger-Einfuhrverordnung)  of 7  Dece•ber 1971 
CBGBl  I  p.  1960,  most  recently  amended  by  the a•ending order of 19  July 
1983  BGBl  I  p ..  958). 
Order  concerning  working  with  ani•al  pathogens  <Tierseuchenerreger-
Verordnung>  of 25  November  1985  CBGBl  I  p.  2123). 
Order  concerning  dangerous  substances  CGefahrstoffverordnung)  of  26 
August  1986  CBGBl  I  p.  1470>  chap.  14-36. 
3 !  aw  on  lllorh dortors.  mahtu  li'noinr:frs  and  other  e.xperts  on  occupational 
safpty  <Arbeitssich~rheitsgesetz> of 12  December  1973  <BGBl  I  p.  1885). 
Directives  on  protection from  hazards  presented  by  nucleic  acids  formed 
by  in vitro recombination  <fifth revision>,  Bundesanzeiger  No  109 of  20 
June  1986. 
~ccident prevention regulations 
·- Works  doctors  VBG  123 
- Occupational  preventive medicine  VBG  100  Cand  implementing orders> 
-- Hf!al~h service  VBG  103 
- Biotechnology  VBG  102 
DENMARK 
There  are specific regulations for sewage  work,  including  provisions 
for  certain vaccinations  (polio  and  tetanus>,  and  for  genetic enginee-
ring,  'including those specifying  containment  levels for  a  prior  risk 
assessment,  which  also involves  classification of the biological  agent 
concerned. 
Other  areas of work  activity in which  there is a  risk of exposure  to 
biolog.ical  agents  are  covered  by  the  general  provisions of  Danish  law 
on  the working  environment  and  the protection of workers.  Under  these 
provisions  employers  must  ensure that the working  environment  is  safe 
and  that it does  not  constitute a  risk to health of workers. 
The  Danish  Ministry of Public Health is  publishing  guidelines  and 
recommendations  of  the risks of  infection with  contagious  diseases 
such  as  hepatitis  B and  AIDS.  Since these guidelines  are mainly  con-
cern~d  with  the protection of  public  health,  they  outline  general 
hygiene  measures  and  do  not take the specific  conditions  of  some 
workers  into consideration. 
SPAIH 
In  addition to provisions of  a  general  nature on  the health of workers 
<general  health  law>  and  on  occupational  diseases,  regulations  have 
been  adopted  on  medical  examinations  and  the organization of  •edical 
services,  as well  as on  industrial  medical  services. 
4 Preventive  measures  are  included  in the  general  regulation on  hygiene 
and  safety at work  and  in the  general  law  on  social  security. 
5Pveral  specific provisions  are  contained  in  the  general  regulations 
on  sanitar1,.•  measures  for foodstuffs  (£Q!J!:~_9l!!!i!l!:!l!:9riYa>,  aedi co-
therapeutic  equipment,  preventive medicine  and  hygiene  in  hospitals, 
abattoirs  and  meat  which  is intended for  export  to  other  Member 
States.  The  legislation also  includes  an  obligation to provide notifi-
cation of  some  infectious diseases. 
Lastly,  a  law  has  been  passed on  toxic  and  dangerous  waste. 
FRAHCE 
General  regulations on  hygiene  and  health apply. 
These  provide speci fica  11 y  for 
all  types of  pollutants which  can  be  released in work  areas  to  be 
collected at source; 
- the  atmosphere  of  workrooms  to  be  protected from  all  sources  of 
infection; 
the  cleaning of rooms  in which  organic substances are  handled; 
- the availability of showers  for  dirty or  unhealthy work. 
In  addition,  every  new  product  which  comes  onto the market  must  be 
studied  and  appraised  by  the relevant authorities. 
GREECE 
There  is no  specific legislation governing the  exposure of workers  to 
biological  substances. 
However,  Chapter 5  of General  Law  No  1568/85 on the  hygiene  and  safety 
of workers  contains articles on  the  general  principles for  preventing 
occupational  diseases,  including those resulting from  biological  a-
gents. 
Special  legislation  is  planned for  tanneries,  abattoirs  and  meat 
shops.  In  addition,  commissions  on  infectious in hospitals  are  res-
ponsible for  applying  codes of  practice. 
5 No  data  are  available on  the  number  of  workers  concerned  and  the  type 
of  biological  substances to which  they  are  exposed. 
IRELAND 
Under  public  health  legislation,  the  Director of Community  Care  <Medi-
cal  Officer  of Health>  can  make  enquiries  about  the  spread  in  the 
community  of  biological  agents  that can  involve  a  risk.  There is also 
some  factory  legislation  <worker  protection>  relating specifically to 
dnthrax  <wool  and  hair,  hides  and  skins). 
ITALY 
Occupational  safety legislation in Italy does  not  include  a  comprehen~ 
sive  set of  preventive or protective measures for workers  exposed  to 
risks fro• biological  agents at work.  Presidential  Decree  No  303  of  19 
March  1956,  entitled "General  regulations  governing occupational  hy~ 
giene",  provides  for  periodic  preventive medical  examinations  for 
workers  exposed  to the risk of  leptospirosis  <for those  working  in 
sewers,  canals  and  marshland>,  ankylostomiasis  <for those  working 
underground  and  in brick furnaces),  carbuncles  and  glanders  <for those 
working  in  veterinary  hospitals,  slaughterhouses,  carcass  du•ps, 
tanning  factories,  rendering  plants  and  for those  involved  in  th~ 
collection  of  animal  waste>,  tuberculosis  and  syphilis  <for  those 
working  in  non-mechanized  glass  blowing). 
Under  laws  No  292  of 5  March  1963  and  No  149  of 20  March  1968,  as well 
as the Health Ministry  Decrees of  16  and  22  SepteMber  1975,  far•hands, 
shepherds,  livestock farmers,  stablehands,  jockeys,  people  involved  in 
tending  racecourse  tracks,  refuse  collectors,  platelayers,  road~ 
workers,  building workers,  asphalters,  rag-and-bone  men,  refuse  hand-
lers,  paper  and  board manufacturers  and  railway,  harbour  and  dock 
workers  are  all  required to  have  an  anti-tetanus vaccination.  Lastly, 
Law  No  1033  of  14  December  1970  on  financial  measures to  combat  tuber-
culosis  prescribes vaccination for  workers  in hospitals,  clinics and 
psychiatric hospitals  <and  for their families>,  •edical  students  and 
soldiers with  a  negative cutireaction. 
6 ·--------
General  provisions are  contained  in the  basic  Law  of 28  August  1924  on 
the  health  and  safety of workers in factories,  industrial  and  commer-
cial  enterprises,  and  of those  employed  in  construction,  development, 
repair  or  excavation work.  More  specific decrees  have  been  issued on 
the basis of his  law. 
Moreover,  the  Law  of  16  April  1979  on  dangerous,  unhealthy or unplea-
sant  working  premises  provides for  operating  licences to  be  granted 
for  such  premises  on  a  case-by-case  basis. 
tfETHERLANDS 
The  Law  on  the working  environment  includes  general  provisions  on 
occupational  health care  and  the safety of workers. 
There  are  no  specific natl  on a  1  provisions on the  protection of workers 
against  biological  agents,  but  preparatory work  is being carried  out 
in this area. 
PORTUGAL 
A  Statutory 
biological 
1987 
Order  on  the  production,  iaport,  aarketino and  use 
products  intended for veterinary usage  was  published 
of 
in 
Provision  has  been aade for compulsory vaccinations  against  tetanus 
under certain. circUMstances. 
Lastly,  there  is co•pulsory notification in the case of so•e occupa-
tional  diseases  resulting from  exposure to  certain  •icrobiological 
agents. 
UNITED  KIHCDOn 
The  Health  and  Safety at Work  Act  <HSW>  provides  a  general  fra•ework 
for  health and safety at work.  The  Dangerous  Pathogens  and  Genetic 
Manipulation Regulations  impose  only notification requirements.  At  the 
moaent,  detailed  guidance  on  the  assess•ent  and  control  of  hazards 
from  biological  agents is produced  by  the Health  and  Safety  Executive 
<HSE)  in  the form  of  notes  and  codes of practice drawn  up  under  the 
aegis  of  advisory  committees  <the Advisory  Committee  on  Dangerous 
Pathogens  and  the Advisory  Committee  on  Genetic Manipulation>. 
7 Th~  r~quirements of  th~ HSW  Act  of  1974  apply  to  biological  agents,  in 
particular Sections  2  <under  which  it is the  duty of  every  eMployer  to 
ensure,  as far  as  is reasonably  practicable,  the  health  and  safety of 
all  his  0r  her  employees>  and  3  thereof  <which  stipulates  that  eM-
ployers  anrt  the self-employed must  conduct  their undertakings so  as to 
~nsure,  as  far  as  is reasonably  practicable,  that  persons  not  in their 
employment,  who  may  be  affected thereby,  are  not  exposed to risks to 
their health  and  safety). 
The  Health  rlnd  Safety  <Genetic  Manipulation>  Regulations of 1978,  Made 
under  the  HSW  Act,  require that the  HSE  be  notified of  any  intention 
to  carry out  genetic manipulation  as  defined  in the Regulations,  and 
that  details of  individual  experiments  be  provided.  A  consultative 
document  wi 11  be  issued  by  the  He a  1 th  and  Safety CoMMission  on  re"i-
sions  of  these  Regulations,  which  will  include proposals  for  1e 
statutory  obligation  to notify the HSE  of the "use"  of  genetically 
manipulated  organisms  and  the  planned release of such organisMs  into 
the environ•ent.  Both  these activities are at present broadly  covered 
by  voluntary notification schemes. 
There  is no  specific requireMent to provide notification of the  fer-
Mentation  of  non-Manipulated organisMS on  an  industrial  scale or  of 
their release into the  environMent.  However,  the Control  of Pesticides 
Regulations  of 1986,  Made  under  the Food  and  Environ•ent  Protection 
Act of  1985,  provide for statutory powers  to approve  pesticides  <in-
cluding •icroorganisMs)  and  Make  it an  offence to sell,  supply,  store 
or  use  an  unapproved  pesticide.  The  use of non-indigenous  plant  pest 
organisms in  a  fermentation  process requires  a  licence  under the Plant 
Pests  <Great  Britain)  Order of  1980. 
The  HSE  must  be  notified of  any  intention to work  with or  transport 
certain  of the •ost dangerous  pathogens  under the Health  and  Safety 
<Dangerous  Pathogens>  Regulations of 1981.  These Regulations are also 
under  review. 
Experience  to  date in some  "eMber States has  shown  that  the  risks 
arising  from  exposure to biological  agents  at work  •ust be  assessed 
before workers  can  be  given  adequate  protection against the•. 
8 The  assessMent should  enable the nature  and  level  of the following to 
be  deter11ined  : 
-the intrinsic danger of the  agents, 
- exposure or potential  exposure ~f workers to these agents, 
- the  probability/risk of  propagation in the co•aunity. 
Before  a  biological  agent is designated a  health  hazard,  various 
factors  must  be  considered,  such  as existing epidemiological  data  and 
the  guidelines  issued by  the appropriate authorities on  the  way  in 
which  some  agents should  be  controlled. 
The  Hember  States  will  then  have  to  classify  biological  agents 
according to their level  of danger,  using the definitions  proposed  in 
this Directive.  The  classification will  cover research  and  development 
laboratories,  aniaal  and  industrial  processes. 
The  proposal  for  a  Directive includes  a  very clear distinction between 
a  conscious  decision to work  with  biological  agents  <voluntary 
sure)  and  incidental  exposure to agents.  Different  provisions 
been  made  for the two  groups. 
expo-
have 
Biological  agents  for  use  in biotechnologies are  included  in  the 
proposal  for  a  Directive in such  a  way  as to cover the  agents  which 
have  already  been  designated  dangerous  and  are  used for genetic •ani-
pulation,  as well  as those which  can  become  dangerous as  a  result  of 
such manipulation. 
The  proposal  for  a  Directive  aims  to provide  guidelines for  drawing  up 
measures  to  protect  workers  against  agents which  are  known  to  be 
dangerous  and  those which  are suspected of being  dangerous. 
Article 
purpose 
i ncl udi ng 
1  covers •easures of a  general  nature  and states  that  "the 
<of  this  Directive)  is to protect  workers  against  risks, 
the  prevention of such risks,  arising  fro•  exposure  to 
biological  agents at work". 
Article 2  contains definitions of "biological  agents",  "Groups  1-4 of 
biological  agents",  "Microorganisms",  "cell  cultures",  "genetically 
modified  biological  agents",  ''genetic manipulation",  "incidental  expo-
sure  to  bi6logical  agents"  and  a  "conscious  decision to  work  with 
biological  agents  <voluntary  exposure)". 
9 On~ of  ~he ~c~ Pl~~d  ~' tk&  ~~apacJl  ~c Article 3,  which  ldVS  down  the 
scope  of the  Directive.  The  risk must  be  assessed for  each  activity 
and  may  also  be  further  assessed.  This  article also  lays  down  which 
types of  information must  be  used  in the classification of  biological 
agents.  Point  5  states that the  proposal  for  a  Directive  will  not 
apply  to  some  agents,  and  point 6  specifies which  provisions will  not 
apply  to  activities  involving  incidental  exposure  to  biological 
agents. 
Articles  4  and  5  are of  a  general  nature  and  apply  to  incidental 
exposure  and  to activities which  involve  a  conscious  decision to work 
with  biological  agents. 
Article 4  lays  down  the measures for  avoiding the  exposure of  workers 
to biological  agents or,  where  this is not reasonably  practicable,  for 
reducing  the  exposure to as  low  a  level  as is necessary  in order  to 
adequately  protect  the  health  and  safety of the  worker.s  concerned. 
Other  measures  provide for  the  limitation of the  number  of  workers 
exposed,  the  design of work  processes,  collective and  personal  protec-
tion,  adequate  and  information training for  workers,  the use of bio-
hazard signs and  emergency  procedures. 
Article  5  deals with the obligation of employers to provide  inforaa-
tion and  adequate  instruction to workers,  e.g.  on  serious  incidents 
and  accidents. 
Articles  6-12  inclusive contain  provisions applicable only to activi-
ties  which  involve  a  conscious  decision  to  work  with  biological 
agents. 
Article  6  1 ays  down  the aeasures to be taken for  working  clothes, 
personal  protective equipment  and  the  provision of  areas where  workers 
can  eat  and  drink.  They  must  be  provided with skin and  eye antiseptics 
and,  if appropriate,  showers  and  must  not  be  charged for the cost of 
these •easures. 
Under  Article 7,  employers •ust keep  a  record of the workers  involved 
in  the activities involving Group  3  and/or Group  4  biological  agents, 
as well  as of accidents  and  incidents. 
Doctors  and  workers will  also  have  access to these records. 
10 Articl~  8  provid~s for  the  r~placement,  as far  as  possible,  of  a 
hazardous  ag~nt by  a  less hazardous or  non-hazardous  one.  In  addition, 
import~rs  and  suppli~rs must  ~nsure that the  agents  are  not  dangerous 
and  that  th~y  ar~ suitably described,  packed  and  transported. 
Under  Article  9,  employers  must  take  available to  the  responsible 
authorities  information on  the results of assessments,  the nu11ber  of 
workers  exposed,  protective  and  preventive measures,  etc. 
Under  Article 10,  employers  must  give  prior notification of  genetic 
manipulation  or  work  with  a  genetically modified  biological  agent, 
work  with  a  Group  4  biological  agent or the intention  to  introduce 
substantial  changes to  a  procedure of which  notification has  already 
been  provided.  The  content of this notification is also laid down. 
Employers  must  inform  the  responsibl~ authority  forthwith  of  any 
incident that may  have  resulted  in the release of any  biological  agent 
which  could  be  a  hazard to the  h~alth of  work~rs. 
Article  11  obliges employers to  draw  up  written  instructions  which 
include  the procedure to be  used  in the  case of  a  serious  incident. 
Furth~ratore,  workers  or  their representatives 11ust  be  i nforaed  as 
quickly  as  possible when  a  serious accident or  incident occurs. 
Article·  12  lays  down  the requirements for the health surveillance  of 
workers,  which  include,  when  appropriate,  the  use  of  effective vac-
cines  and  the  keeping of  individual  health records. 
Article  13  cov~rs specific measures for  health  care  facilities  and 
diagnostic  laboratories.  Following  the  above~mentioned  assess•ent 
appropriate  measures  will  be  taken  as laid down  in Annex  3  of  the 
proposal  for  a  Directive. 
Article 14  deals with the  physical  containment  levels set out  in Annex 
3  which  are to be  observed for  the manipulation of biological  agents 
in laboratories  (other than  diagnostic  laboratories),  ani•al  rooas  and 
industrial  processes. 
Once  the  hazard  has  been  assessed,  once of three  physical  containment 
levels with different requirements will  be  chosen. 
Certain  measures  listed in  annex  3  shall  be  applied  in an  industrial 
process,  only  when  appropriate. 
11 A  MiniMUM  physical  containMent  level  will  be  used  for  biological 
agents  in  respect of which  it has  not  yet  been  possible to  reach  a 
cone  1  usi ve  assessMent.  "oreover,  when  the vo 1  UMe  of bi o 1  ogi· ca  1  agents 
handled  has reached  a  certain figure,  the physical  containMent  level 
will  be  increased. 
Additional  Measures  are  listed in annex  4  for  laboratories and  aniMal 
rooMs. 
Under  Article 15,  in the section of final  provisions,  the  annexes to 
this Directive  May  be  adapted to technical  progress. 
Under  Article  16,  the  "eMber  States •ust ensure that  workers  are 
consulted on  the  provisions contained in this Directive. 
Under  Article 17,  "eMber  States Must  keep statistics  of 
cases  of  serious  illness  or death  due  to  exposure  to 
agents,  and  publish up-to-date  inforMation on  occupational 
caused  by  biological  agents. 
recognized 
biological 
diseases 
Article  18  1  ays  down  the ti•e scale and  procedures for  apply'i ng  this 
Directive in the "e•ber States. 
Article  19  states  that the Directive is  addressed  to  the  "eMber 
States. 
Annex  1 sets out the criteria to  be  used for designating  a  genetically 
110dified  b'iological  agent "non-hazardous". 
Annex  2  shows  the biohazard sign provided for  'in  Art'icle 4  (g). 
Annex  3  sets out the specific •easures required at each of the  three 
physical  conta'in•ent levels referred to in Articles 13  and  14. 
Annex  4  sets  out  add'itional  Measures  required at each of  the  three 
physical  contain•ent levels for  laboratories and  ani•al  roo•s referred 
to in Art.  14.6. 
Pursuant  to  Article  118A  of the Treaty  establishing 
Econo•'ic  Co.•unity,  the  Council  shall  cooperate with 
Parlia•ent and  consult the  EconoM'ic  and  Social  Co••ittee. 
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the  European 
the  European f!BQE!QSALEQJ:Le 
~QYH~!L_~!Bf~Il~f 
on  the  protection of  workers  from  the risks 
related  to  exposure to biological  agents  at work 
THE  COUNCIL  OF  THE  EUROPEAN  COMMUNITIES, 
Having  regard  to the Treaty establishing the European  Economic  Commu-
nity,  and  in  particular Article  118A  thereof, 
Having  regard to the  proposal  from  the  Commission  (1),  established 
following  consultation with  the Advisory  Committee  on  safety,  hygiene 
and  health protection at work, 
In  co-operation with  the  European  Parliament  (2), 
Having  regard to the opinion of the  Economic  and  Social  Committee  {3), 
Whereas  Council  Directi~e  80/1107/EEC of 27  November  1980  on  the 
protection  of workers  from  the risks related to exposure to chemical, 
physical  and  biological  agents  at work  (4), as  amended  by  the  Act  of 
Accession  of  Spain  and  Portugal,  provides  for  Directives  for  certain 
agents; 
Whereas,  under the terms of the said Directive,  such  protection should 
as  far  as  possible  be  ensured  by  measures to  prevent  exposure  or  to 
keep it at as  low  a  level  as  is reasonably  practicable; 
------------------------
OJ  No 
2  OJ  No 
3  OJ  No 
4  OJ  No  l  327,  3.12. 1980,  p.  8 ldhereas  .more  ,p.reci se :knowledge  of  t:he  risk~ inv.olv.e,d  :i:R  exposur,e  ~t·.o 
.bi-olo_g-i c<il  agents  .at  wor.k  can  'b~  obt,ai ned  ·thro_ugh  4::he  keeping  9f 
rf'c()rds; 
W.he:.reas  emp l o.yers .mu<;t  lke!'!P  .abreast of  new  dev.e l opments  :i.fl  t.echno  1  ()9Y 
with  a  view  to  improving  the .protection of  wo.rkers'  -health  e~nd safety; 
Wh.ereas  it  is necr.:ssary,  in order to  ensure the Jhi.ghest  .degree  .o.f 
p,rotecti on  .reasona·bly  pr.ac:ti cab.le,  that .worker_s  .and  their  r.epr.esen-
tatives  be  ~n;f:ormed  ;abo~:d:  t:he ri.sks  wh•ich  biologii.c~;l  agents  can  p.ose 
for  ·theii r  'h.e,al;th_,  .and  :t~he _meas.ures  ne.ces.sary to  l;ess·en or  ,£:1 im.i:n.a;t,e 
those  risks .and  that ct·hey  should .be  in  a  _pos:i t~ on ·.to  •ensure  ~that  :t\he 
n  ~ces?ary pr.ot.e.ct i ve .m.e,asures  are t.aken' 
:Whereas,  prevent:i ve 'm~as.ures shoul..d  be taken f.or ·.th.e  .;protect:i on .of ·the 
·hP..a;lth  and  safety o.f  worke.r.s  :ex;pos~d to :bLoJog·iJ::.a·il  a~u~nts, 
2 HAS  ADOPTED  THIS  DIRECTIVE: 
1 . 
OBJECTIVE 
!lttitl.!Ll 
The  purpose  of this Directive  is to protect workers 
risks  to  their health  and  safety.  and  to  prevent 
against 
such risks  arising or likely to arise from  exposure to  biologi-
cal  agents at work. 
2.  This  Directive shall  apply  to all  workers  with the exception  of 
workers  engaged  in sea transport  and  in air transport. 
For  the  purposes of this Directive "workers  engaged  in sea trans-
port  and  in air transport"  means  personnel,.  on  board. 
DEFIHITIONS 
For the  purposes of this Directive: 
<a>  "Biological  agents''  are micro-organisms  including  those  which 
have  been  genetically manipulated,  cell  cultures and  multicel-
lular  human  endoparasites. 
Cb>  A  "~~QYILl" biological  agent  is one  that is most  unlikely  to 
cause  human  disease.  It does  not  produce  infection  and  is unlike-
ly to spread  in  the  community. 
This  definition  includes  any  genetically- modified  biological 
agent  which fulfils the criteria for  good  microbiological  prac-
tice as  laid down  in Annex  1. 
(C)  A "g!:Q!JQ_Z"  biological  agent is one  that may  cause  human  disease 
and  might  be  a  hazard  to workers.  It rarely  produces  infection. 
It  is  unlikely to spread in the  community  and  there is  usually 
effective  prophylaxis or treatment  avai 1 able·. 
3 ( rO  A  "grQ!Jp_J"  hi o 1  ogi ca  1  agent  i o;.  one  that may  cause severe  human 
disease  and  presents  a  serious hazard to workers.  It may  present 
a  risk of spread  in the  community  but  there is usually  effective 
prophylaxis or treatment available. 
<e)  A  "GrQ!HL9"  biological  agent  is one  that  causes  severe  human 
disease  and  is a  serious hazard to workers.  It may  present  a  high 
risk of spread  in the  community  and  there is usually  no  effective 
prophylaxis or treatment  available. 
<f>  "Microorganism"  is  any  microscopic  unicellular or  subcellular 
biological  entity capable of replication. 
(g)  "Genetically modified  biological  agent''  is an  organism  derived  by 
the techniques of  genetic  manipulation. 
Chl  "<;enetic  manipulation"  is the formation  of  a  new  combination  of 
genetic  material  by  the  insertion of  nucleic  acid  molecules 
produced  by  whatever  means  outside the cell,  into  any  virus, 
bacterial  plasmid  or other vector system so  as to  allow  their 
incorporation into  a  host organism  in which  they  do  not  naturally 
occur  but  in which  they  are  capable of  continued  propagation. 
<il  "Cell  culture" is the in vitro growth  of  cells  isolated  from 
multicellular organisms. 
Cj)  "Incidental  exposure to biological  agents"  is any  work  activity 
or  sector of  activity in which  there is no  deliberate  intention 
to  handle  or  use  biological  agents  but  where  the work  activity 
may  result in workers  being  exposed  to  biological  agents,  in-
cluding  contact with  animals  and  animal  products where there may 
be  a  risk of  exposure to zoonotic  agents,  and  sewage  and  health 
care  activities where  they  may  be  a  risk of exposure to  persons 
or  pathological  material  with  infectious disease. 
Ckl  "Conscious  decision to work  with  biological  agents"  is any  work 
activity  or sector of activity in  which  the  purpose of the  work 
is to handle or  use  biological  agents,  including work  in research 
laboratories or industrial  processes  employing  biological  agents. 
4 ASSESSMENT 
1 .  Th'i s  Directive  sha  11  app  1  y  to work  acti viti  e:s  i n  whi ch  workers 
are or are.potentially  exposed to biological  agents  as  a  result 
of their work  activities. 
2.  In  the  case  of any  activity or sector of  activity  likely  to 
involve  a  risk of  exposure to biological  agents the risk must  be 
assessed.  Meaber  States sha  11  fix the conditions of this assess-
ment  and  of any  further  assessuent.  if  necessary.  and  shall 
determine  by  whom  it is to  be  conducted.  The  assessment shall  be· 
conducted so as to  determine the  nature  and  degree of the: 
- inherent hazard of a  biological  agent to health  ; 
- risk  of workers'  exposure or potential  exposure.  including  a 
determination of whether this involves either 'inc'idental  expo-
sure.  or  a  conscious  dec'ision to work  with  biological  agents; 
- risk of transfer fro• the workplace to the co•aunity; 
- risk of further spread within the coamunity. 
This  assessment shall  not  apply to genetically •od'ifi ed  bioloai.-
cal  agents which  have  been  notified  in  accordance  with  the  p~bvisions 
of Counci 1  Direct'ive  I  /EEC  /on  deliberate  release  into the  envirrn-
ment  of  genetically-modified organis•s7 (1) 
3.  The  identif'ication of a  biolog;cal  agent  as  being  hazardous  to 
health shall  be  based.~n all  avail~ble infor11ation  including  : 
- a  disease from  which  a  worker is found to be  suffer'ing  wh'ich 
has  a  direct  connection with  h'is  work  act'ivity and/or epide•'io-
logy  which  indicates that a  biological  agent  has  been  a  source 
of  human  infection and/or illness; 
- guide  H nes  issued  by  a  responsible authority  which  indicate 
that  a  biological  agent  should  be  controlled in  so•e  way  in 
order  to  prevent  human  infection and/or illness when  workers 
are or are potentially exposed to such  an  agent  as  a  result  of 
their work  activity. 
1)  OJ  .......  . 
5 4.·  R1ological  agent5 shall  be  assessed on  the  basis of  the  maximum 
degree of  hazard,  unless there is evidence,  in  individual  cases, 
that the  degree of  hazard  is lower. 
The  assessment  of  a  genetically-modified biological  agent  shall 
be  made,  when  appropriate,  on  the same  basis. 
S.  This  Directive shall  apply  without  prejudice  to  the  provisions 
of  Council  Directive 
modified  microorganisms. 
on  the  contained  use  of  genetically-
6.  Articles 4 to 17, with  the exception  of  Article 9, first indent,  shall  not  apply  if the 
assessment  referred  to in  paragraph 2  shows  that  the  exposure 
and/or  potential  exposure is to  a  Group  1  biological  agent  or to 
a  biological  agent  which  causes  disease only  in  animals  and/or  in 
plants  and  that there is no  identifiable  health risk to workers. 
7.  Articles  6  to  14  shall  not  apply  if  th~ as~essment 
referred to  in  paragraph 2  shows  that the work  activities involve 
only  incidental  exposure to  biological  agents. GFNFRAL  PROVISIONS  APPLICABLE  TO  WORK  ACTIVITIES  WHICH  INVOLVE 
ROlH  ItiCIOENTALFXPOSliRE  TO  BIOLOGICAL  AGENTS  AND  A CONSCIOUS 
DECISION  TO  WORK  WITH  BIOLOGICAL  AGENTS 
The  risk  of workers •  · exposure  must  be  avoided.  Where  this  is  not 
reasonably  practicable,  having  regard to the work  activity  and  the 
risk  assessment referred to  in Article 3,  paragraph 2,  exposure shall 
be  reduced  to  as  low  a  level  as is necessary  in  order  to  protect 
adequately the  health  and  safety of  the workers  concerned,  in  parti-
cular  by  the following  measures  which  are to  be  applied when  appro-
priatE:: 
<a>  tht=:  limitation of the  number  of  workers  exposed or 
r:xposed; 
potentially 
Cb>  the  prevention of  exposure or its adequate  control  by  the  appro-
priate  design  of work  processes  and/or  the  use  of  engineering 
control  measures; 
<c>  collective  protection measures  including the  use  and  maintenance 
of  adequate  equipment; 
<dl  .Personal  protection measures,  where  exposure  cannot  reasonably  be 
avoided  by  other means; 
(e)  hygiene  measures  designed to  prevent the  accidental  transfer  or 
release of  a  biological  agent  from  the workplace; 
(f)  the  provision  of up-to-date  information on  biological 
which  are  or  may  be  present  at the workplace  together 
c~ntinuing programme  of  adequate training for  workers; 
(g)  use  of  a  biohazard sign  <Annex  2>  and  other warning signs; 
agents 
with  a 
<h>  emergency  procedures  designed to minimize  workers'exposure  re-
sulting from  a  serious  accident or incident. 
7 1.  At  the  beginning  of  employment  and  at  regular  intervals 
thereafter,  the  workers  shall  receive  up  to  date  information 
together with  adequate  instruction,  so that they  are  made  aware 
of  all  the  requirements  laid  down  in Article 4. 
2.  Appropriate measures shall  be  taken to  ensure that workers  and/or 
any  workers'  representatives in the  undertaking or  establishment 
receive  explanations on  the  potential  risks to health  from 
exposure to biological  agents,  the  hygiene  requirements,  and  the 
emergency  procedures  designed to minimize  workers'  exposure  re-
sulting from  a  serious accident or  incident. 
ADDITIONAL  PROVISIONS 
APPLICABLE  TO  WORK  ACTIVITIES  WHICH  INVOLVE 
A CONSCIOUS  OECISION  TO  WORK  WITH  BIOLOGICAL  AGENTS 
1.  Appropriate  measures  shall  be  taken so far  as  is  reasonably 
practical  for  the  protection of  the  health  and safety of workers 
by  providing that  : 
<a>  areas  are  set  aside where  workers  can  eat  and  drink  without 
risking contamination  by  biological  agents. 
<b>  workers  are  provided  with  appropriate  protective  clothing  or 
other  appropriate special  clothing; 
<c>  separate  storage  places  are  provided for  working  or  protective 
clothing  and  for street clothes; 
<d>  protective  respiratory  equipment  is placed in  a  well-defined 
place  and  is checked,  if possible before,  and  in  any  case  after 
each  use;  defective  equipment shall  be  repaired  or  replaced 
before further  use. 
B 2.  .Working  clothes  and  personal  protective  equipment,  including 
protective  clothing  which  a1ay  be  contaminated  by  biological 
ag~nts,  must  be  removed  on  leaving the working  area  and  stored 
separately  ·from  other  clothing.  The  employer  must  ensure  that 
such  clothing  and  personal  protective  equipment  are  disinfected, 
cleaned or,  if  necessary~  destroyed. 
3.  Workers  who  handle  biological  agents  ~ust be  provided with  skin 
and  eye  antiseptics,  suitable washing facilities  and,  if appro-
priate,  showers. 
4.  Workers  may  not  be  charged for  the  cost  of  measures  taken 
pursuant to  paragraphs 1,  2  and  3. 
1. 
Brti&l.fLl 
Employers  shall  keep  a  record of workers  exposed or potential-
ly exposed to Group  3  and/or  Group  4  biological  agents indicating 
the type of work  done,  and  whenever  possible the  biological  agent 
to  which  they  may  have  been  exposed,  as  well  as records  of 
accidents  and  incidents,  as  appropriate; 
2.  The  records  referred to  in  paragraph  1 shall be 
3. 
4. 
kept  for  at  least  10 years following  the  end  of  exposure,  in 
accordance  with  national  laws .and  practice. 
The  doctor  and/or  the  authority  responsible for  health  and  safety 
at work  shall  have  access to the records referred to  in  paragraph  1 • 
.  fach  worker  shall  have:  access to information in the records which 
relates to  him  personally. 
5.  WorkP.rs  and/or  any  workers'  representatives in the undertaking or 
est  ab 1  i shment  shall. have  access to  anonymous  co  11 ecti  ve  i nforma-
tion in the records. 
9 1.  The  use of  a  Group  3  or 4  biological  agent shall  be  avoided,  as 
far  as  is reasonably practicable1 by  its replace•ent  by  a  less 
hazardous or  non-hazardous  agent. 
2.  Suppliers or iaporters of a  Group  3  or 4  biological  agent for  use 
at work  shall  ensure that they  are  adequately  described,  packed 
and  transported. 
1 . 
E•ployers  shall  on  request make  available  to  the  responsible 
authorities  appropriate infor•ation on: 
the  results  of the assess•ent referred to in  Article  3(2); 
the activities in which  workers  have  been  exposed or  poten-
tially exposed to biological  agents; 
the number  of workers  exposed; 
the  name  of the  person responsible for safety  and  health at 
work; 
the  protective  and  preventive  •easures  taken  including 
working  procedures  and  •ethods, 
an  eaergency  plan for the  protection of workers fro•  expo-
sure  to  a  Group  3  or 4  biological  agent which •ight  result 
from  a  loss of physical  containaent. 
t:n:::titl!L!O 
Without  prejudice to  Directive  I  /EEC  on  the deliberate 
release  of  genetically-modified organisms,  employers  shall  give 
a prior notification to  the  responsible  authority,  at  Least 
60  days  before: 
- an  intention to carry out genetic manipulation work  or to  work 
with  a  genetically-.odified biological  agent  in  Group  2,  3  or  4; 
- an  intention to  introduce substantial  changes to  a  procedure 
which  has  already  been  notified; 
10 ·_.,._~··=~.r  ····.-·.-·~-····  • 
,., 
'- . 
::l. 
1 . 
1Jl•:>!'k  with  a  Group  4  biological  agent,  or if there  is dn  lnten-
tion to  hdndle,  store or transport  such  dn  dgent. 
In  the  case  of  genetic manipulation  work,  or  ~ork with  a  geneti-
~2lly  -modified  biologicdl  agent, 
include  : 
prior notification  shall 
-the  name  and  address  of the  undertaking  and/or  establishment 
and  the  name  of  the  person  responsible for safety  and  health at 
work. 
In the case of  a  Group  4  biological  agent 
shall  inr:lude  : 
prior notification 
- the  result of  the  assessment  referred to in Article  3(2); 
-the name  of  thP.  biological  agent; 
- thP.  protection  and  preventive measures that  are  envisaged; 
- the  name  of the  person responsible for safety and  health  at 
work. 
Employers  shall  inform  forthwith the responsible authority  of 
any  accident or  incident that may  have  resulted  in the release of 
any  biological  agent such that it could  cause severe  human  infec-
tion  and/or  illness. 
Employers  shall  display written instructions at the  workplace 
which  shall  include the  procedure to  be  used  in the  case  of 
a  serious accident or  incident. 
- work  with  a  Group  4  biological  agent. 
2.  A  seT"ious  dccident or incident shall be  reported  immediately  to 
and  recor-ded  by  the  per·son  responsible for the work. 
3.  Workers  and/or  any  workers'  representatives in the  undertaking or 
establishment  shall  be  informed  as quickly  as  possible  when  a 
s_eri ous  accident or incident occurs,  of  the  causes thereof,  and 
of the measures  taken or to  be  taken to rectify the situation  . 
. 11 1.  The  specific rules for  the  health surveillance of workers  shall 
be  established  by  Member  States in accordance with  national 
law  and  practice. 
2.  Members  States  shall  make  arrangements to  ensure  that,  where 
relevant,  each worker  can  undergo  an  assessment of  his state  of 
health  prior to potential  exposure.  This  assessment  should  be 
such  that  it is directly possible to implement  individual  and 
hygiene  measures. 
3.  Where  relevant, the assessment  referred to in paragraph  2 should  identify those workers  for 
whom  special  protective measures  may  be  required.  When  appro-
priate,  effective  vaccines should  be  made  available  for  those 
workers  who  are  not  already  immune  to the  biological  agent  to 
which  they  are  exposed or are potentially exposed. 
4.  If  a  worker is found  to be  suffering froa  an  infection  and/or 
illness which  is suspected of being the result of  exposure,  the 
doctor  or  authorities responsible for  health  surveillance  may 
decide  that other workers simi  ·1 arly  exposed shall  undergo  assess-
ments  of  th~ir state of  health,  and  may  require  a  reassessment of 
the risk of  exposure  as referred to in Article 3(2). 
5.  When  the  assessments  referred  to  in this Article  have  been 
made,  an  individual  health reco1·d  shall  be  kept for  at least 10 
years following  the  end  of  exposure,  in accordance with  national 
laws  and  practice. 
The  doctor  ot•  authority responsible for  health surveillance  aay 
propose  protective measures to  be  taken in respect of any  indivi-
dual  worker. 
6.  The  worker  concerned or the employer  may  request  a  review of the 
assessments  referred  to  in this Article,  in  accordance  with 
national  laws  and  practice. 
12 "'  '• 
SPECIAL  MEASURES  FOR 
HEALTH  CARE  FACILITIES  AND 
DIAGNOSTIC  LABORATORIES 
Article  13 
1.  Specific  measures shall  be  taken for  health care facilities,  in 
particular isolation  and  post-mortem  units,  and  clinical,  veteri-
nary  and  diagnostic laboratories. 
2.  For  the  purposes  of the  assessment referred to in 
Article 3C2),  particular attention shall  be  paid to 
uncertainties  about  the  presence of biological  agents-in  the 
•aterials and  specimems  being  investigated. 
-the  hazard of biological  agents  known  or suspected to be  pre-
sent in the materials or specimems. 
- the risk posed  by  the  nature of the work  activity. 
3.  The  specific measures  listed in Annex  3  for the  physical  contain-
ment  of biological  agents shall  be  applied,  when  appropriate. 
SPECIAL  MEASURES  FOR  INDUSTRIAL  PROCESSES, 
LABORATORIES  AND  ANIMAL  ROOMS 
1.  Specific measures shall  be taken for  industrial  processes,  animal 
rooms  and  laboratories,  excluding clinical,  veterinary  and  diag-
nostic  1 aboratori es  in order to  ensure the  physical  contai maent 
of  a  Group  2,  3  or 4  biological  agent. 
For  this  purpose Member  States shall  classify biological  agents 
using  the  definitions in Article 2  (c),  (d)  and  <e>  relating 
respectively to  a  Group  2,  3,  and  4  biological  agent. 
2.  Following  the  assessment  referred to in Article 3(2), 
special  measures  shall  be  taken  as  laid down  in Annex  3  after 
matching  the  physical  containment  level  for  biological  agents 
with  the  degree of risk. 
For  this purpose  work  activities involving 
13 a  group  2  biological  agent  may  be  carried out only  in  worki~g 
areas  corresponding to at least the  physical  contain•ent  level 
2. 
- a  group  3  bi o  1  ogi ca  1  agent  may  be  carried out  on.l y  in  working 
areas  corresponding to at  least the  physical  containment  level 
3 .. 
- a  group  4  biological  agent  may  be  carried out only in  working 
areas corresponding to the  physical  containment  level  4. 
3.  When  the volume  of the  biological  agents  which  are being  handJed 
in  groups  2  and/or  3,  j usti t;  es it the  physical  contaimnent  1  evel 
shall  be  increased,  when  appropriate,  to at least the  level  3  or 
at 4  respectively,  in order to  ensure that the health and  safety 
risks are  minimized. 
4.  In  an  industrial  process in which  there  is  adequat.e  ·Physical 
containment of  biological  agents  by  means  of  a  closed syst.ea,  the 
specific  measures  listed in points  1  and  2  of Annex  3  shall  be 
applied only  when  appropriate. 
5.  In  the  case of  a  biological  agent  in respect of  which  a  con-
clusive  assessment  has  not  yet  been  possible as referred to  in 
Article 3  (2),  but the  i ndi cations are that a  risk  to 
health  might  arise from  the  proposed  use,  then work  activities 
may  be  carried out only  in working  areas  corresponding  to  at 
least the physical  containment  level  3. 
6.  The  additional  measures  required for  laboratories  and  animal 
roo111s  are  listed in Annex  4. 
FINAL  PROUISIOHS 
8J:titlJL1~ 
The  Annexes  to this Directive may  be  adapted to technical  .progress  in 
accordance  with  the  procedure set out  in Article  10  of  Directive 
80/1107/EEC. 
BttilliLl~ 
"ember  States  shall  ensure that workers  andl'or workers'  representa-
tives  where  they exist in an  undertaking or establishment  are  .con-
sulted  on  the  provisions referred to in this Directive  and  that  they 
can  be  involved  in their application. 
14 Brtitl!LlZ 
1.  Member  States shall  keep  national  statistics of recognized  cases 
of  serious illness or death  due  to  exposure to biological  agents 
at work. 
2.  Member  States shall  publish  up  to date  and  appropriate  informa-
tion on  occupational  diseases caused  by  biological  agents. 
Brti.~;l.Ll~ 
1.  Hember  States shall  adopt  the  laws,  regulations  and  administra-
tive provisions  necessary to  comply  with this Directive before  1 
January  1992.  They  shall  immediately  inform  the  Commission 
thereof. 
2.  "ember  States shall  communicate  to the Commission  the provisions 
of  national  law  which  they  adopt  in the field  governed  by  this 
Directive. 
Artij;l.fL.12 
This  Directive is addressed to the Hember  States. 
15 
Done  at Brussels, 
For  the Council 
The  President For  genetically  modified  micro-organisms  the criteria  have  to  be 
established  which  permit  a  comparison of such  micro-organisms  with 
natural  micro-organisms,  in  order .to  be  able to  determine to  which 
group  they  belong  and  therefore which  level  of  physical  confinement 
I 
should  be  applied. 
In this annex  the following  definitions are  given: 
Annex  1 
Host  organism:  is  the organism  into which  donor  DHA  is inserted in r-
DHA  constructions;  provides the major  portion of  the 
genome  of the r-DHA  organism;  same  as recipient. 
Vector  An  agent  of transmission;  for  example  a  DHA  vector  is  a 
self-replicating  molecule  of  DNA  that  transmits  genetic 
information  from  one  cell  or organism to  another.  Plamids 
<and  some  viruses)  are  used  as "vectors" for  DHA  in  bacte-
rial  cloning. 
The  genetically  modified micro-organism will  have  essentially  the 
properties  of the  host,  the  genetic material  of which is most  often 
found  integrated in the  genetically modified micro-organism with only 
one  foreign  fragment  more. The  following  table  sets  out  the criteria for  good  microbiological  practice  CGI'IP>  as 
r~ferred to  in Article 2  <b>  for  a  genetically modified  biological  agent. 
Host  Organism  rONA  Engineered  Organism  Vector/Inser-t 
I  I 
---------------------------~-----------------------------------~----------------------------
-Non-pathogenic; 
- No  adventitious agents; 
- Extended  history of safe 
industrial  use;  OR 
- Built-in limitations 
permitting optimal  gro~th 
in industrial  setting but 
limited survival  without 
adverse  consequences 
outside the industrial 
setting 
- Non-Pathogenic;  - Well  characterized  and 
free  from  known  harm-
full  sequences; 
!  -As safe in industrial  setting  !  -
as  host organism,  but with 
Liuited in size as much 
as possible to the  DNA 
required to  perform 
the intended function; 
should  not  increase the 
stability of the cons-
truct  Cunless that is a 
requirement of the in-
tended function>; 
limited survival  without  adverse! 
consequences for  human  health 
- Should  be  poorly 
mobi 1 isabl e; 
- Should  not transfer  any 
resistance markers to 
micro-organisms  not 
known  to acquire them 
naturally  Cif such  ac-
quisition could  compro-
mise  use of drug to con-
trol  disease agents> . 
.  I 
---------------------------~---------------------------------------------------------------
There  are two  clear  examples of other classes of organisms that warrant the  GMP  designation 
unless they  are  pathogenic: 
i )  Those  constructed  entirely from  a  single prokaryotic host  <including 
plasmids  and  viruses>  or from  a single eukaryotic  host  <including 
mitochondria or plasmids- but  excluding viruses->;  and 
its  indigenous 
its  choroplasts, 
iil  Those  consisting entirely of  DNA  segments  from  different species that exchange  DNA  by 
known  physiological  processes. 
For  the  purpose of this table "non-pathogenic"  means  an  agent  which  does  not:  cause  human 
disease BIO-HAZARD  SIGN  AS  REFERRED 
TO  IN  ARTICLE  4.g. 
ANNEX  2 -----··  - ..  ~----- -·-· -- --:,---· ---
THE  SPECIFIC  MEASURES  REQUIRED  AT  EACH  OF  THE  THREE  PHYSICAL 
CONTAINMENT  LEVELS  AS  REFERRED  TO  IN  ARTICLES  13,  PARAGRAPH  3 
AND  14  PARAGRAPHS  2,  3,  4  AND  5 
Containment  levels 
I  ------------------------------------------ Specific measures 
2  3  4 
I  I  I  I 
~----------------------------------------------~-------------~-------------~------------- ., 
.1.  The  workplace is to  be  in  an  isolated 
.. ,part  of  a  bui 1 ding  and  separated by  an 
anteroom  with  two  doors 
Recommended  Yes 
I  I  I  I 
Yes 
~----------------------------------------------~-------------·-------------~-------------
2.  Input  air  and  extract air to the workplace!  No 
are to be  filtered  using  <HEPA>  or likewise 
!. Yes,  on 
extract air 
I  I  I  I 
Yes,  on 
input .and 
extract air 
~----------------------------------------------~-------------~-------------~-------------
3.  Access is to  be  restricted to  nominated 
workers  only 
Recommended  Yes 
! 
!  Yes.  vj a  an 
!  airlock 
I  I  I  I 
~----------------------------------------------~-------------~-------------~-------------
4.  The  workplace is  to  be  sealable to 
permit disinfection 
No  Recommended 
I  I  I 
Yes 
----------------------------------------------~---------------------------~------------· 
5.  Specified disinfection procedures  !  Yes  !  Yes  !  Yes 
I  I  I 
-----------------------------------------------~-------------·-------------·--------------
!  6.  The  workplace is  to be  maintained  No  Recommended  Yes 
!  at  an  air pressure  negative to atmosphere 
I  I  I  I 
~----------------------------------------------~-------------~-------------~-------------
7.  Efficient vector control  e.g.  rodents 
and  insects 
Recommended  Yes 
I  I  I  I 
Ves 
~----------------------------------------------~-------------~-------------~-------------
·!  8.  Co 11 ecti on  and  treatment of effluents  !  No  !  Recommended  !  Yes 
I  I  I  I 
-----------------------------------------------~-------------~---------------------------·~ 
9.  Surf  aces  ;·.,pervious to water  Yes,  for 
bench 
Yes,  for 
bench  and 
floor 
Yes,  for 
bench,  floor 
and  ceilings 
I  I  I  I 
~----------------------------------------------~-------------·-------------~------~------ I. 
!  10.  Surfaces resistant to acids,  alkalis, 
!  solvents,  disinfectants 
Recommended  Ves  Ves 
I  I  I  I 
.~----------------------------------------------~-------------~-------------·-------------· 
ll. Safe storage of  a  biological  agent  Reco~~mended  Yes  !  Ves,  secure 
!  storage 
I  I  I 
----------------------------------------------~-------------~-------------~-------------THE  ADO:lTIONAL  MEASURES  REQUIRED·  AT  EACI!t;  OF  liHE  TARH  PHYSICAL 
CONTAIHMENT  LEVELS  FOR  LABORATORIES·  AND  AHIMAL  R00t15 
AS  REFERRED  TO  lH'  ARTICLE  14,  PARAGRAPH·  6• 
-~-------------------------------------------------------.....,;--·---------··-..;..·------......-...... .-. __ ..  _____  ...... _-_._. .. 
Conta1n-.aent  levels 
I  I 
~-------.--~----------------·-----------.-.  ...... ___  ...., . 
Specific: measures. 
I'  !'  3  I'  4 
t  I  ~  ~  f 
~----------------------~~----------------------~---------------------------~---~-------~-· 
1 .  An observ·atton  window.,  ov  altel"nat'i ve·, 
is to be  present,  so that occupants  can  be 
•·  s.een· 
Recommended  Recommended  v·es 
I' 
! 
I  I  I'  I· 
~--------------------------------.-..-----·-------------------------o..::o.----·---------------------·-----
I>  I' 
~  2.  A<  laboratory· is to contain owri  eq.ui pment  !  No  !'  Reco•aended  !  Ves 
I·  •  I  t·  I 
..=...----------------------------------------------"!-.&.~-------------~-------------·.-..-----..-..--·--._.-
I• 
!  3'.  A  M.ic:robi.ologi'cal  safety cabi'net;  ts to 
!  be·  used 
!  Re«!:o•mended·  !  Yes· 
!' 
!  Yes,  with 
r glove  ports 
I' 
I  I  I  I  I' 
-----------------------------------------------~-----~----·--~--~-~---~--~~~---·---------· 
4.  Infected •aterial  includi:ng  any  anim·al' 
is to. be  handled  ; n  a  safety cabinet  or· 
i sc  1: at; or 
Rec:o•llended!  ve·s 
! 
I 
Ves 
~----------------------------~----~--------~---l--~----------1----------~--l------'-------! 
!  r 
!  5.  Autoclave or incinerator· for  ani·11als  !'  Ves• 
I·  I  I  I  I 
~------------------------------------~----~----~-------------~-------------~-------------· FINANCIAL  SHEET 
relating to the proposal ior a  Council  Directive 
on the protection of workers 
from  the risks related to exposure 
to biological agents at work 
1.  Budget  item concerned 
B  6482  :  Health protection,  hygiene  and safety at work 
A  2510  :  Compulsory consultation 
2.  Legal  basis 
a)  Article  118A  of the  EEC  Treaty added  by the Single 
European Act 
b)  Commission  communication  on  its programme  concerning 
safety,  hygiene  and health at work  (SEC(87)1216). 
3.  Proposal  for classification as compulsory or 
non-compulsory  expenditure 
Non  compulsory 
4.  Description and grounds  for the action 
'  4.1.  Description 
4.1.1.  Aims  of the proposal  for  a  Directive 
The  aim  of  the  proposal  is  to  protection  workers 
from  risks to their health  and  safety  which  arise 
or  could  arise  from  exposure  to biological  agents 
at work,  especially the prevention of such risks. 
4.1.2.  Features  of  the  proposal  for  a  Directive 
(especially those with  financial  implications) 
Harmonization of national  legislation in the field 
of  the  protection  of  workers  from  biological 
agents,  by  means  of  adequate  monitoring,  training 
and  information  of ·workers  and  the  provision  of 
physical protection measures. 4.2. 
- 2  -
Grounds 
The  action  is  justified 
indicated  under  point 
implications  are  inherent 
the Directive. 
on  the  legal  ground 
2.  The  financial 
in  the  application  of 
5.  Nature of expenditure and method of calculation 
5 .1. 
5.2. 
5.3. 
Nature  of  additional  activities  to  be  undertaken 
after adoption of the Directive 
a)  monitoring  the application  of the  Directive at 
Member  State level  ; 
b)  consultation of experts  ; 
c)  operation of the Committee. 
Types  of  activities  deriving  from  point  5.1.  and 
their financial  implications 
It involves  : 
- study  contracts  to  examine  problems  related  to 
the operation of the Directive in practice, 
- costs for consultation meetings with experts, 
- operating costs of committees. 
Calculation of expenditure 
In  view  of  the  nature  of  the  activities,  it  is 
impossible  to  estimate  the  expenditure  precisely. 
The  amounts  under point 6.1 are overall estimates. 
6.  Financial  impact of the action on appropriations 
6.1.  Schedule of commitment  and  payment  appropriations 
1989 
1990 
1991 
1992 
1993 
Total 
B  6482 
CA  (ECU) 
80.000 
80.000 
90.000 
100.000 
110.000 
460.000 
A  2510 * 
CA  (ECU) 
30.000 
60.000 
60.000 
60.000 
60.000 
270.000 
B  6482 
PA  (ECU) 
80.000 
80.000 
90.000 
100.000 
110.000 
460.000 
A  2510 
PA  (ECU) 
30.000 
60.000 
60.000 
60.000 
60.000 
270.000 
6.2.  Share of Community  financing  (in  %)  in the overall 
cost of the action  :  100  % 
7.  Comments 
None. 
* As  ~oncerns the  p~t  A 2510,  the  credits  foreseen  can  only  be  used  within 
the  limits of  theavailable  budgetary  provisions .• 
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8.  Financial  impact  on staff appropriations 
8.1.  Staff  needed  solely  for  the  execution  of  the 
action 
From  1989  one  full-time  category  A  official,  one 
half-time  category  B  official  and  one  full-time 
category c  official. 
The  necessary  staff  will  be  obtained  through 
internal  redeployment  or  in  the  framework  of  the 
annual  budgetary procedure. 
8.2.  Staff appropriations needed 
From  1989  an  estimated  158.000  ECU  per  year  will 
be required. <Directive on  biological  agents> 
I.  The  proposed Council  Directive is designed to protect workers from  the 
risks related .to  exposure to biological  agents at work. 
II.  The  main  activities to which  the Directive applies are: 
research  and  development  laboratories 
hospital  isolation departments 
clinical  and  veterinary  diagnostic laboratories 
industries using  biological  agents  £medical  industries - vaccines] 
the sewage  industry 
breweries. 
As  regards the relative nu•bers of s•all  and  •ediu•-sized undertakings 
involved  in each of these activities,  •ediu•-sized  undertakings  are 
concentrated  Mainly  in the  brewing  and  •edical  industries,  whereas 
there are very few  small  undertakings in these two  branches. 
III.  Fro• the cost angle,  the •ost iMportant articles concern 
- the reduction of worker  exposure, 
-the  introduction  of specific measures  appropriate to the  intrinsic 
risk of the organisms, 
- medical  surveillance. 
The  Directive is structured in such a  way  that different •easures  are 
laid  down  for  activities which  •ay involve  incidental  exposure  to 
biological  agents  (the  degree of risk is smaller  and  the •easures  are 
therefore  less  stringent - in particular,  they  do  not  require  the 
drawing  up  or  keeping of registers>  and  for activities  involving  a 
conscious  decision to work  with biological  agents  <the  degree of  risk 
is higher  and  the measures laid down  are therefore stricter>. ..  . 
- 2  -
The  heaviest  direct costs have  be~n identified as those  relating  to 
medical  surveillance.  However,  these will  vary froe one  Meaber  State to 
another,  since  some  Member  States already  have  such surveillance sys-
tems,  while  in others they  have  not  been  required until  now . 
IU.  It  should  be  pointed out that other indirect costs may  be.incurred  in 
the  application of the Directive,  since the individual  Member  States 
may  lay  down  more  stringent protective measures for workers than  those 
prov·i ded  for  in the Directive.  Clearly,  the 1 eve  1  of such costs cannot 
be  estimated,  since  it  depends  on  the  political  and  legislative 
approach  chosen  by  each Member  State and  the stage reached  in  existing 
legislation and  scientific development  in each  country. 
u.  The  Directive  avoids  imposing  administrative,  financial  or 
traints  likely  to  hamper  the creation  and  development  of 
medium-sized  undertakings.  As  has  already  been  pointed out, 
few  small  and  medium-sized  unde:rt.aki.ngs  are  involved  in 
connect~d with the handling of  biological  agents. 
legal  cons-
small  and 
only  a  very 
activities 
However,  1 arge  undertakings  may  have  an  advantage  over  s•all  and 
medium-sized  undertakings,  since  the higher the  number  of  workers 
subject  to  medical  surveillance the lower the average  cost  for  each 
assessment.  In order to keep  these costs to  a miniaum,  the obligations 
relating  to medical  surveillance have  been  adapted so  as to fit in  as 
far  as  possible with  existing systems. 
UI.  The  information  given  above is based on  the conclusions of  a  study  of 
·the. igpact of the  proposed  Directive on  sMall  and  medium-s1zed  under~ 
takings  carried out  by  the National  Institute of  Occupational  Health 
CDenmarkl.  However,  the  conclusions,  not sufficiently representative of 
·well---founded  in that sor;ae  l'tember  States,  such as  France,  the  United 
Kingdolll  and  the  Federal  Republic of Germany,  did  not supply  data. 
VII.  The  advantages anti  c1 pated  fro111  the  improve111ent  in working  conditions 
will  stem  from  a  better a..,areness  of the health problems  related  to 
work· with  biological  agents  and  a  consequent reduction in the  health 
risks which  such work  111ight  pose.  These  improvements will  benefit  not 
only society as  a  whole. but also individual  undertakings.  In the latter 
case,  undertakings  will  certainly benefit froiD  the reduction in  the 
number  of  days lost through sickness. 
UIII.The  Advisory Conmittee for Safety,  Hygiene  and  Health  Protection  at 
Work  gave  an  opinion on  2  and  3  July  1987 on  the necessary content of a 
proposal  for  a  D-irective  in this field.  The  Coaaittee members  confined 
themselves to technical  questions only,  and  the proposed  Directive has 
been  adapted to take account of their opinion. 